Milestones in the biology and pharmacology of histamine H 1-receptor antagonists

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 34, 1997, Pages 7-13

  Marone, Gianni ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Basophils; Cetirizine; Histamine; Mast cells

Indexed keywords

CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGY; ANAPHYLAXIS; BASOPHIL; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; REVIEW;

HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTORY, 20TH CENTURY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION;

EID: 0030997380     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04806.x     Document Type: Article

References (94)

1. Marone G. Human basophils and mast cells. Biological Aspects. Basel, Karger, 1995.
2. Dale HH, Laidlaw PP. The physiological action of ß-imidazolyl- ethylamine. J Physiol 1910;41:318-44.
3. Dale HH, Laidlaw PP. Histamine shock. J Physiol 1919; 52:355-90.
4. Bovet D, Staub AM. Action protectrice des éthers phéno-liques au cours de l'intoxication histaminique. Compt Rend Soc Biol 1937;124:547-9.
5. Staub AM, Bovet D. Action de la thymoxyéthyldiéthyl-amine (929 F) et des éthers phénoUques sur le choc anaphylactique du cobaye. Compt Rend Soc Biol 1937; 125:818-23.
6. Lichtenstein LM, Osier AG. Studies on the mechanisms of hypersensitivity phenomena. XII. An in vitro study of the reaction between ragweed pollen antigen, allergic human serum and ragweed-sensitive human leukocytes. J Immunol 1966;96:169-79.
7. Plaut M, Lichtenstein LM. Histamine, 5-hydroxytryp-tamine, SRS-A: Discussion of type I hypersensitivity (anaphylaxis). In: Vane JR, Ferreira SH, eds. Handbook of Experimental Pharmacology. Vol. 50/1. Inflammation. New York: Springer Verlag, 1978;345-73.
8. Kahlson G, Rosengren E. New approaches to the physiology of histamine. Physiol Rev 1968;48:155-96.
9. Marone G. The role of basophils and mast cells in the pathogenesis of pulmonary diseases. Int Archs Allergy Appi Immunol 1985;76 (suppl. l):70-82.
10. Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G. Human basophil/mast cell releasa-bility. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma and from broncho-alveolar lavage in asthmatics. Am Rev Respir Dis 1989; 139:1375-82.
11. De Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 1992;99:723-8.
12. De Paulis A, Marinò I, Ciccarelli A, De Crescenzo G, Concardi M, Verga L, et al. Human synovial mast cells. I. Ultrastructure in situ and in vitro immunologic characterization. Arthritis Rheum 1996;39:1222-33.
13. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. I Immunol 1995;154:2855-65.
14. Patella V, Bouvet J-P, Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J Immunol 1993;151:5685-98.
15. Patella V, De Crescenzo G, Marinò I, Genovese A, Adt M, Gleich GJ, et al. Eosinophil granule proteins activate human heart mast cells. J Immunol 1996;157:1219-25.
16. Casolaro V, Spadaro G, Patella V, Marone G. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. J Immunol 1993;151: 5563-73.
17. Dvorak AM. Ultrastructural localization of histamine in human basophils and mast cells; changes associated with anaphylactic degranulation and recovery demonstrated with a diamine oxidase-gold probe. Allergy 1997;52:12-22.
18. Ash ASF, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol 1966;27:427-39.
19. Black JW, Duncan WAM, Durant CI, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature 1972;236:385-90.
20. Roszkowski W, Plaut M, Lichtenstein LM. Selective display of histamine receptors on lymphocytes. Science 1977; 195:683-5.
21. Lichtenstein LM, Gillespie E. Inhibition of histamine release by histamine controlled by H2 receptor. Nature 1973;244:287-8.
22. Rocklin RE, Haberek-Davidson A. Histamine activates suppressor cells in vitro using a coculture technique. J Clin Immunol 1981;1:73-9.
23. Osband ME, Cohen EB, Miller BR, Shen Y-J, Cohen L, Flescher L, et al. Biochemical analysis of specific histamine Hj and H2 receptors on lymphocytes. Blood 1981;58:87-90.
24. Cameron W, Doyle K, Rocklin RE. Histamine type I (HJ receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J Immunol 1986;136: 2116-20.
25. Villemain FM, Bach J-F, Chatenoud LM. Characterization of histamine Hi binding sites on human T lymphocytes by means of 125I-Iodobolpyramine. Preferential expression of Hi receptors on CD8 T lymphocytes. J Immunol 1990; 144:1449-54.
26. 2 receptors. J Exp Med 1991;174:281-4.
27. 3) of histamine receptor. Nature 1983;302:832-7.
28. ++ channels. J Pharmacol Exp Ther 1994;269: 221-9.
29. Imamura M, Seyedi N, Lander HM, Levi R. Functional identification of histamine H3-receptors in human heart. Circ Res 1995;77:206-10.
30. 1 receptor. Biochem Biophys Res Com 1993;197:1601-8.
31. 2 receptor. Proc Natl Acad Sci USA 1991; 88:429-33.
32. Simons FER, Simons KJ. The pharmacology and use of Hr receptor-antagonist drugs. N Eng J Med 1994;330:1663-70.
33. Snowman AM, Snyder SH. Cetirizine: actions on neurotransmitter receptors. J Allergy Clin Immunol 1990;86: 1025-8.
34. Charlesworth EN, Massey WA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of Hx receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-70.
35. Mitchell EB, Chapman MD, Pope FM, Crow J, Jouhal SS, Platts-Mills TAE. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982;1:127-30.
36. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991; 144:51-8.
37. Kimura I, Moritani Y, Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973;3:195-202.
38. Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, et al. Identification of basophils by immuno-histochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993;23:919-25.
39. Sparrow D, O'Connor GT, Rosner B, Weiss S. Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: the normative aging study. Am J Respir Crit Care Med 1994;149: 376-81.
40. Clark RAF, Gallin JI, Kaplan AP The selective eosinophil chemotactic activity of histamine. J Exp Med 1975;142: 1462-76.
41. Massey WA, Lichtenstein LM. The effects of antihistamines beyond Hi antagonism in allergic inflammation. J Allergy Clin Immunol 1990;86:1019-24.
42. Ciprandi G, Buscaglia S, Pesce G, Passalacqua G, Rihoux IP, Bagnasco M, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995;95:612-21.
43. Fasce L, Ciprandi G, Pranzato C, Cozzani S, Tosca MA, Grimaldi I, et al. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272-6.
44. Holgate ST, Finnerty JP. Antihistamines in asthma. J Allergy Clin Immunol 1989;83:537-47.
45. Dirksen A, Engel T, Frolund L, Heinig JH, Svendsen UG, Weeke B. Effect of a non-sedative antiMstaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover trial. Allergy 1989;44:566-71.
46. 1-receptor antagonist in the treatment of grass pollen sensitive asthma. Br J Clin Pharmacol 1990;30:229-35.
47. Bousquet J, Godard P, Michel FB. Antihistamines in the treatment of asthma. Eur Respir J 1992;5:1137-42.
48. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991;324:1785-90.
49. Fadel R, Herpin-Richard N, Rihoux JP, Henoco E. Inhibitory effect of cetirizine 2HC1 on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
50. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
51. Varney V, Gaga M, Frew AJ, De Vos C, Kay AB. The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992;22:43-9.
52. Jinquan T, Reimert CM, Deleuran B, Zachariae C, Simonsen C, Thestrup-Pedersen K. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol 1995;95:979-86.
53. Lichtenstein LM, Gillespie E. The effects of the Ht and H2 antihistamines on 'allergic' Mstamine release and its inhibition by histamine. J Pharmacol Exp Ther 1975;192: 441-50.
54. Koller M, Hilger RA, Rihoux JP, Kônig W. Cetirizine exerts anti-inflammatory effects on human neutrophils. Int Arch Allergy Immunol 1996;110:52-6.
55. 2 release from mast cells of human lung, tonsil, and skin. Allergy 1994;49:246-53.
56. Charlesworth EN. The role of basophils and mast cells in acute and late phase reactions in the skin. Allergy 1997;52:29-41.
57. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177:605-11.
58. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179:703-8.
59. Moqbel R, Ying S, Barkans J, Newman TM, Kimmit P, Wakelin M, et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995; 155:4939-47.
60. Lim KG, Wan H-C, Bozza PT, Resnick MB, Wong DTW, Cruikshank WW, et al. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemo-attractant factor) and RANTES. J Immunol 1996;156: 2566-70.
61. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ontani H, Nagura H, et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-a in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992;7:385-92.
62. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
63. Okayama Y, Petit-Frére C, Kassel O, Semper A, Quint D, Tunon-De-Lara MJ, et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995;155:1796-1808.
64. Del Carpio J, Kabbash L, Turenne Y, Prévost M, Hébert J, Bedard PM, et al. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:741-6.
65. Falliere CJ, Brandon ML, Buchman E, Connel JT, Dockhorn R, Léese PT, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991;66:257-62.
66. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br J Dermatol 1988;119:67-71.
67. Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P, et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990;64:191-4.
68. Paul E, Bödeker RH. Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind study in 45 patients. Eur J Clin Pharmacol 1986;31: 277-80.
69. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CTC, Hindley F, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987; 117:81-8.
70. JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
71. Malick A, Grant JA. Antihistamines in the treatment of asthma. Allergy 1997;52:52-63.
72. Advenier C, Queille-Roussel C. Rational use of antihistamines in allergic dermatological conditions. Drugs 1989;38:634-44.
73. Berth-Jones J, Graham-Brown RAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989;121:635-7.
74. Marone G, Giugliano R, Lembo G, Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986;87:19-23.
75. Greenberger PA, Patterson R. Radin RC. Two pretreatment regimens for high-risk patients receiving radiographic contrast media. J Allergy Clin Immunol 1984;74: 540-3.
76. Lasser EC, Berry CC, Talner LB, Santini LC, Lang EK, Gerber FH, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-9.
77. Simons FER, Kesselman MS, Giddins NG, Pelech AN, Simons KJ. Astemizole-induced torsade de pointes. Lancet 1988;II:624.
78. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moyé L. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994;73:346-52.
79. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993 ;269: 1532-6.
80. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G. Effect of activation of the receptor on coronary hemodynamics in man. Circulation 1986;73:1175-82.
81. Vigorito C, Marone G, Condorelli M. Cardiovascular effects of histamine and sulfidopeptide leukotrienes. In: Human Inflammatory Disease. Clinical Immunology. Vol. 1 (Eds. Marone G, Lichtenstein LM, Condorelli M, Fauci AS). B.C. Decker Inc., Toronto, 1988; p. 107-23.
82. Marone G, de Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A. Immunological characterization and functional importance of human heart mast cells. Immuno-pharmacology 1995;31:1-18.
83. Bhatti JZ, Hindmarch I. The effects of terfenadine with and without alcohol on an aspect of car driving performance. Clin Exp Allergy 1989;19:609-11.
84. 1-antagonist, loratadine. Eur J Clin Pharmacol 1987;32:419-421.
85. 1-receptor antagonists. Allergy 1997;52:65-76.
86. 2 receptors. J Am Coll Cardiol 1987;10:1207.
87. Patella V, de Crescenzo G, Lamparter-Schummert B. Adt M, De Rosa G, Marone G. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res 1997;46 (suppl. 1):S3-S4.
88. Sale ME, Barbey JT, Woosley RL, Edwards D, Yeh J, Thakker K, et al. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994;56:295-301.
89. Meininger CJ. Mast cells and tumor-associated angio-genesis. In: Human Basophils and Mast Cells: Clinical Aspects. Vol 62 (Ed: Marone G). Basel, Karger, 1995; pp. 239-57.
90. Frase RA, Simpson JG. Role of mast cells in experimental tumour angiogenesis. In: Development of the Vascular System. (Eds. Nugent J, O'Connor M). Ciba Foundation Symposium 100. London, Pitman, 1983; pp. 120-31.
91. Zauberman H, Michaelson IC, Bergmann F, Maurice DM. Stimulation of neovascularization of the cornea by biogenic amines. Exp Eye Res 1969;8:77-83.
92. Roche WR. The nature and significance of tumour-assisted mast cells. J Pathol 1986;148:175-82.
93. Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986;55:289-94.
94. Schatz M, Hoffman CP, Zeiger RS, Falkoff R, Macy E, Mellon M. The course and management of asthma and allergic diseases during pregnancy. In: Allergy: Principles and Practice (4th ed). Vol 2 (Eds: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW). St. Louis, Mosby-Year Book, 1993; pp. 1301-42.